Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment
Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its Enzalutamide Tablets, available in 40 mg and ... Read More
Zydus Lifesciences receives tentative FDA approval for Letermovir tablets
In a significant development for patients undergoing bone marrow or kidney transplants, Zydus Lifesciences Limited has been granted tentative approval by the United States Food ... Read More
Zydus Lifesciences gains FDA approval for Finasteride and Tadalafil Capsules
In a significant development for the pharmaceutical industry, Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, has secured final approval from the United States ... Read More